-
Mashup Score: 5Long-Term Health Outcomes of Huntington Disease and the Impact of Future Disease-Modifying Treatments | Neurology Clinical Practice - 13 hour(s) ago
Background and ObjectivesDisease-modifying treatments (DMTs) such as gene therapy are currently under investigation as a potential treatment for Huntington disease (HD). Our objective was to estimate the long-term natural history of HD progression and …
Source: www.neurology.orgCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 5Long-Term Health Outcomes of Huntington Disease and the Impact of Future Disease-Modifying Treatments | Neurology Clinical Practice - 29 day(s) ago
Background and ObjectivesDisease-modifying treatments (DMTs) such as gene therapy are currently under investigation as a potential treatment for Huntington disease (HD). Our objective was to estimate the long-term natural history of HD progression and …
Source: www.neurology.orgCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 5Long-Term Health Outcomes of Huntington Disease and the Impact of Future Disease-Modifying Treatments | Neurology Clinical Practice - 2 month(s) ago
Background and ObjectivesDisease-modifying treatments (DMTs) such as gene therapy are currently under investigation as a potential treatment for Huntington disease (HD). Our objective was to estimate the long-term natural history of HD progression and …
Source: www.neurology.orgCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 10Novel analysis methods used for Huntington's disease - 4 month(s) ago
The genetic disease Huntington’s not only affects nerve cells in the brain but also has widespread effects on microscopic blood vessels according to research.
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 19Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington’s disease - 1 year(s) ago
Nature Medicine – Microglia mediate the early and selective degeneration of corticostriatal synapses and the development of cognitive deficits in presymptomatic Huntington’s disease via the…
Source: www.nature.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Disparities in Huntington Disease Severity - 1 year(s) ago
Background and Objectives Social and structural determinants of health (SDOH) have been associated with disability in neurologic diseases. However, the association between these factors and disability in Huntington disease (HD) has not been studied. This study aimed to evaluate the association of racial and sociodemographic factors with disease severity in patients with HD in North America. Methods We conducted a cross-sectional study of genetically confirmed participants with HD (36+ CAG repeats) in the North American region using the ENROLL-HD 2020 periodic dataset. In this analysis, our exposure variable was the participant’s race/ethnicity. The main outcome measure was disease severity, as measured by the Total Functional Capacity Score (TFC), which measures the level of disability of patients with HD. We used multivariate regression models to adjust for sociodemographic factors that may mediate or moderate a causal effect between race/ethnicity and disease severity. Results Among
Source: cp.neurology.orgCategories: Latest Headlines, NeurologyTweet-
This study found that Black participants in North America presented to the ENROLL-HD study with more advanced #Huntington disease than White participants. It also found higher education was associated with less advanced disease when entering the study. https://t.co/SzUXYTzYgE https://t.co/xRcC2wxxoC
-
-
Mashup Score: 6VGLUT3 deletion rescues motor deficits and neuronal loss in the zQ175 mouse model of Huntington's disease - 1 year(s) ago
Huntington’s disease (HD) is an autosomal-dominant neurodegenerative disease characterized by progressive motor and cognitive impairments, with no disease-modifying therapies yet available. HD pathophysiology involves evident impairment in glutamatergic neurotransmission leading to severe striatal neurodegeneration. The vesicular glutamate transporter-3 (VGLUT3) regulates the striatal network…
Source: Journal of NeuroscienceCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 7M2 Cortex Circuitry and Sensory-Induced Behavioral Alterations in Huntington's Disease: Role of Superior Colliculus - 1 year(s) ago
Early and progressive cortico-striatal circuit alterations have been widely characterized in Huntington’s disease (HD) patients. Cortical premotor area, M2 cortex in rodents, is the most affected cortical input to the striatum from early stages in patients and is associated to the motor learning deficits present in HD mice. Yet, M2 cortex sends additional long-range axon collaterals to diverse…
Source: Journal of NeuroscienceCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Cognitive Impairment in Huntington Disease | CME Institute - 1 year(s) ago
An updated review of pathophysiology, emerging treatments, and supportive care strategies in the cognitive dimension of Huntington disease.
Source: education.cmeinstitute.comCategories: Latest Headlines, PsychiatryTweet
-
Mashup Score: 9Study: Drug significantly reduces chorea symptoms in patients with Huntington's disease - 1 year(s) ago
The drug valbenazine statistically improves chorea, a movement disorder commonly associated with Huntington’s disease, when compared to a placebo, according to a recent international study led by UTHealth Houston researcher Erin Furr Stimming, MD, who served as principal investigator on behalf of the KINECT-HD Huntington Study Group.
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet
A novel #Huntington disease (HD)-modeling framework estimates HD progression over a lifetime and the lifetime costs and quality-adjusted life years (QALYs): https://t.co/t7XejVfCYy https://t.co/SwkXmFuWkp